Showing results (1091-1100 of 5,693) with videos related to
Sort By:
Pageof 570
The Oncologist|April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.The Oncologist|March 14, 2022
Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung CancerChristopher A Lemmon, Emily C Zabor, Nathan A PennellThe Oncologist|July 29, 2022
International Survey on Frailty Assessment in Patients with CancerGiuseppe Luigi Banna, Ornella Cantale, Maria Monica Haydock, et al.The Oncologist|April 19, 2019
A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain MetastasesNan Bi, Yuchao Ma, Jianping Xiao, et al.The Oncologist|April 19, 2019
A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast CancerMichael Shafique, Roohi Ismail-Khan, Martine Extermann, et al.The Oncologist|August 22, 2018
Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective StudyLijia Xie, Seema Nagpal, Heather A Wakelee, et al.The Oncologist|August 22, 2018
Alerta Rosa: Novel Alert and Navigation Breast Cancer Program in Nuevo Leon, Mexico, for Reducing Health System Interval DelaysTeresa Mireles-Aguilar, Jaime Tamez-Salazar, Jose F Muñoz-Lozano, et al.The Oncologist|April 19, 2018
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant GliomaMary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, et al.The Oncologist|April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaKelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.The Oncologist|April 14, 2018
The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and DiagramsOmar Lababede, Moulay A MezianePageof 570